Moreover, by investigating the efficacy of 1-PPA in inhibiting NASH progression, we also found that 1-PPA, through the inactivation of PAR2, determines a down-regulation of the early transcription factor CCAAT Enhancer Binding Protein beta (C/EBP-β). The gene discussed is F2RL1; the disease is metabolic dysfunction-associated steatohepatitis.